FONAR CORP (FONR) Stock Overview
USA - NASDAQ:FONR - US3444374058 - Common Stock
FONR Key Statistics, Chart & Performance
The current stock price of FONR is 15.39 USD. In the past month the price increased by 2.19%. In the past year, price increased by 0.85%.
FONR Latest News, Press Relases and Analysis
FONR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.37 | 220.36B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.34 | 195.51B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.23 | 149.61B | ||
| SYK | STRYKER CORP | 29.26 | 143.72B | ||
| MDT | MEDTRONIC PLC | 16.86 | 119.59B | ||
| BDX | BECTON DICKINSON AND CO | 12.91 | 52.80B | ||
| IDXX | IDEXX LABORATORIES INC | 52.82 | 50.75B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.98 | 48.25B | ||
| RMD | RESMED INC | 26.87 | 37.44B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.04 | 36.25B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.25 | 26.29B | ||
| DXCM | DEXCOM INC | 40.72 | 27.15B |
Related stock screener links
About FONR
Company Profile
FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. The company is headquartered in Melville, New York and currently employs 535 full-time employees. The firm conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Company Info
FONAR CORP
110 Marcus Dr
Melville NEW YORK 11747 US
CEO: Raymond V. Damadian
Employees: 520
Phone: 16316942929
FONAR CORP / FONR FAQ
Can you describe the business of FONAR CORP?
FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. The company is headquartered in Melville, New York and currently employs 535 full-time employees. The firm conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Can you provide the latest stock price for FONAR CORP?
The current stock price of FONR is 15.39 USD. The price increased by 0.39% in the last trading session.
What is the dividend status of FONAR CORP?
FONR does not pay a dividend.
What is the ChartMill technical and fundamental rating of FONR stock?
FONR has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is FONR stock listed?
FONR stock is listed on the Nasdaq exchange.
Who owns FONAR CORP?
You can find the ownership structure of FONAR CORP (FONR) on the Ownership tab.
FONR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to FONR. When comparing the yearly performance of all stocks, FONR is a bad performer in the overall market: 69.25% of all stocks are doing better.
FONR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to FONR. While FONR has a great health rating, its profitability is only average at the moment.
FONR Financial Highlights
Over the last trailing twelve months FONR reported a non-GAAP Earnings per Share(EPS) of 1.16. The EPS decreased by -19.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.48% | ||
| ROA | 3.6% | ||
| ROE | 4.52% | ||
| Debt/Equity | 0 |